SLC40A1 and Alzheimer disease: Additionally, evidence suggests that loss of the iron exporter protein ferroportin 1 (Fpn 1) participates in neuronal loss and memory impairment in AD, and targeting Fpn 1 or inhibiting ferroptosis could be a promising therapeutic strategy for AD [14].